Cart
sales@molnova.com
NK-252
CAS No. 1414963-82-8
NK-252( —— )
Catalog No. M23569 CAS No. 1414963-82-8
NK-252 is a potential activator of Nrf2. It has great Nrf2-activating potential.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 30 | In Stock |
|
| 5MG | 47 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 135 | In Stock |
|
| 50MG | 230 | In Stock |
|
| 100MG | 423 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNK-252
-
NoteResearch use only, not for human use.
-
Brief DescriptionNK-252 is a potential activator of Nrf2. It has great Nrf2-activating potential.
-
DescriptionNK-252 is a potential activator of Nrf2. It has great Nrf2-activating potential.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNuclear Receptor/Transcription Factor
-
TargetKeap1-Nrf2
-
RecptorNrf2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1414963-82-8
-
Formula Weight285.26
-
Molecular FormulaC13H11N5O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:29 mg/mL (101.66 mM)
-
SMILESO=C(NCC1=NC=CC=C1)NC2=NN=C(C3=CC=CO3)O2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shimozono R et al. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model. Mol Pharmacol. 2013 Jul, 84(1):62-70.
molnova catalog
related products
-
ML334
ML334 (LH601A) is a transmembrane and potent NRF2 activator that inhibits Keap1-NRF2 protein interactions to ameliorate myocardial infarction-induced cardiac fibrosis by inhibiting cardiac fibroblast activation and proliferation.
-
L-Cystine dihydrochl...
L-Cystine dihydrochloride is an Nrf2 inducer with whitening and anti-dark spot effects.L-Cystine dihydrochloride has cytoprotective effects in cells, and is often added to various fungal cultures as a carbon source.
-
AEM1
AEM1 is an inhibitor of deregulated NRF2 transcriptional activity in cancer.
